embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference
Rhea-AI Summary
Embecta (Nasdaq: EMBC) has announced its participation in the upcoming J.P. Morgan Global Leveraged Finance Conference in Miami. The company's Chief Financial Officer, Jake Elguicze, is scheduled to deliver a presentation on Tuesday, February 25, 2025, at 3:00 p.m. ET.
Positive
- None.
Negative
- None.
News Market Reaction – EMBC
In the trading session that priced this news, EMBC gained 1.05%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET.
About embecta
embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
